Cargando…
High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression
Tryptase(+) mast cells (MCs), abundant in the invasive front of tumours, contribute to tissue remodelling. Indeed, protease-activated receptor-2 (PAR-2) activation by MC-tryptase is considered an oncogenic event in colorectal cancer (CRC). Recently, we have suggested NHERF1 as a potential new marker...
Autores principales: | Malfettone, Andrea, Silvestris, Nicola, Saponaro, Concetta, Ranieri, Girolamo, Russo, Antonio, Caruso, Stefano, Popescu, Ondina, Simone, Giovanni, Paradiso, Angelo, Mangia, Anita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3780541/ https://www.ncbi.nlm.nih.gov/pubmed/23991686 http://dx.doi.org/10.1111/jcmm.12073 |
Ejemplares similares
-
VEGF, HIF-1α Expression and MVD as an Angiogenic Network in Familial Breast Cancer
por: Saponaro, Concetta, et al.
Publicado: (2013) -
Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis
por: Malfettone, Andrea, et al.
Publicado: (2012) -
Correlation between Serum Tryptase, Mast Cells Positive to Tryptase and Microvascular Density in Colo-Rectal Cancer Patients: Possible Biological-Clinical Significance
por: Ammendola, Michele, et al.
Publicado: (2014) -
Serum tryptase, mast cells positive to tryptase and microvascular density evaluation in early breast cancer patients: possible translational significance
por: Marech, Ilaria, et al.
Publicado: (2014) -
Targeting Mast Cells Tryptase in Tumor Microenvironment: A Potential Antiangiogenetic Strategy
por: Ammendola, Michele, et al.
Publicado: (2014)